Olesoxime: Completed Phase Ib enrollment

Trophos completed enrollment of 44 patients with stable RRMS receiving interferon (IFN) beta in the double-blind, placebo-controlled, French Phase Ib Translate MS-Repair trial evaluating 495 mg oral o...